Latest News from JointMedica

A recent systematic review and meta-analysis evaluated the outcomes of hip resurfacing arthroplasty (HRA) in patients with mild developmental dysplasia of the hip (DDH; Crowe I/II). The review screened 65 articles, with 11 met inclusion criteria, totalling 895 patients and 1,006 hips with DDH, with a mean follow-up of 7.1 years.  Key Findings: ·        Pooled survivorship was 93% and complications occurred in 13% of cases. ·        No statistically significant difference in r

The Polymotion® Hip Resurfacing (PHR®) IDE study has officially passed the 60% enrolment mark , bringing us another step closer to...

A recent study published in International Orthopaedics (2025) reports the longest follow-up to date on the outcomes of hip resurfacing arthroplasty (HRA) in patients under the age of 30. Conducted by Girard et al. at the University of Lille, the research addresses a critical gap in orthopaedic literature, as few long-term data have been available for such a young and active patient population. The retrospective study reviewed the clinical data, and patient recorded outcome me

We’re proud to share that we have successfully completed the 100th surgery in our ongoing U.S. Investigational Device Exemption (IDE)...

Z. Wong et al. conducted a retrospective, propensity score–matched study comparing Hip Resurfacing Arthroplasty (HRA) and Total Hip...

Momentum Builds as Polymotion® Hip Resurfacing IDE Study Reaches 30% Enrolment and Expands to Nine Active Sites. We are pleased to...

In a recent network meta-analysis, “Hip resurfacing arthroplasty reduces dislocation and infection rates without differences in clinical...

In a systematic review published earlier this year, Marwin et al. (2025) stated, “There is no significant difference in postoperative...